- Home
- MDBH vs CASI Comparison
MDBH vs CASI Comparison
Compare MDBH & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDBH
- CASI
- Stock Information
- Founded
- MDBH 1997
- CASI 1991
- Country
- MDBH United States
- CASI China
- Employees
- MDBH N/A
- CASI N/A
- Industry
- MDBH
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- MDBH
- CASI Health Care
- Exchange
- MDBH Nasdaq
- CASI Nasdaq
- Market Cap
- MDBH 38.2M
- CASI 35.8M
- IPO Year
- MDBH 2023
- CASI 1996
- Fundamental
- Price
- MDBH N/A
- CASI $2.00
- Analyst Decision
- MDBH
- CASI Strong Buy
- Analyst Count
- MDBH 0
- CASI 1
- Target Price
- MDBH N/A
- CASI $4.00
- AVG Volume (30 Days)
- MDBH 13.3K
- CASI 307.1K
- Earning Date
- MDBH 11-11-2025
- CASI 11-13-2025
- Dividend Yield
- MDBH N/A
- CASI N/A
- EPS Growth
- MDBH N/A
- CASI N/A
- EPS
- MDBH 0.56
- CASI N/A
- Revenue
- MDBH N/A
- CASI $31,564,000.00
- Revenue This Year
- MDBH N/A
- CASI N/A
- Revenue Next Year
- MDBH N/A
- CASI N/A
- P/E Ratio
- MDBH $6.02
- CASI N/A
- Revenue Growth
- MDBH N/A
- CASI 36.64
- 52 Week Low
- MDBH $3.16
- CASI $1.09
- 52 Week High
- MDBH $9.42
- CASI $7.50
- Technical
- Relative Strength Index (RSI)
- MDBH 45.38
- CASI 55.82
- Support Level
- MDBH $3.33
- CASI $1.77
- Resistance Level
- MDBH $3.55
- CASI $2.08
- Average True Range (ATR)
- MDBH 0.19
- CASI 0.19
- MACD
- MDBH 0.00
- CASI 0.04
- Stochastic Oscillator
- MDBH 40.92
- CASI 89.15
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.